1. Pelle MT. Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Rosacea. Fitzpatrick's dermatology in general medicine. 2008. 7th ed. New York: McGraw-Hill;703–709.
2. Wilkin JK. Rosacea. Pathophysiology and treatment. Arch Dermatol. 1994. 130:359–362.
Article
3. Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004. 51:327–341.
Article
4. Rosen T, Stone MS. Acne rosacea in blacks. J Am Acad Dermatol. 1987. 17:70–73.
Article
5. Berg M. Epidemiological studies of the influence of sunlight on the skin. Photodermatol. 1989. 6:80–84.
6. Pelle MT, Crawford GH, James WD. Rosacea: II. Therapy. J Am Acad Dermatol. 2004. 51:499–512.
Article
7. Plewig G, Kligman AM, Jansen T. Acne and rosacea. 2000. 3rd ed. Berlin, London: Springer;455.
8. Berg M, Liden S. An epidemiological study of rosacea. Acta Derm Venereol. 1989. 69:419–423.
9. Wilkin J, Dahl M, Detmar M, Drake L, Feinstein A, Odom R, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2002. 46:584–587.
Article
10. Wilkin J, Dahl M, Detmar M, Drake L, Liang MH, Odom R, et al. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2004. 50:907–912.
Article
11. Sobye P. Aetiology and pathogenesis of rosacea. Acta Derm Venereol. 1950. 30:137–158.
12. Marks R, Harcourt-Webster JN. Histopathology of rosacea. Arch Dermatol. 1969. 100:683–691.
Article
13. Sibenge S, Gawkrodger DJ. Rosacea: a study of clinical patterns, blood flow, and the role of Demodex folliculorum. J Am Acad Dermatol. 1992. 26:590–593.
Article
14. Grilli R. Helicobacter pylori: related to rosacea? J Am Acad Dermatol. 2000. 42:536–537.
Article
15. Marks R. Concepts in the pathogenesis of rosacea. Br J Dermatol. 1968. 80:170–177.
Article
16. Nunzi E, Rebora A, Hamerlinck F, Cormane RH. Immunopathological studies on rosacea. Br J Dermatol. 1980. 103:543–551.
Article
17. Hertzman AB, Randall WC. Regional differences in the basal and maximal rates of blood flow in the skin. J Appl Physiol. 1948. 1:234–241.
Article
18. Ryan TJ. The blood vessels of the skin. J Invest Dermatol. 1976. 67:110–118.
Article
19. Lonne-Rahm SB, Fischer T, Berg M. Stinging and rosacea. Acta Derm Venereol. 1999. 79:460–461.
Article
20. Chen DM, Crosby DL. Periorbital edema as an initial presentation of rosacea. J Am Acad Dermatol. 1997. 37:346–348.
Article
21. Quarterman MJ, Johnson DW, Abele DC, Lesher JL Jr, Hull DS, Davis LS. Ocular rosacea. Signs, symptoms, and tear studies before and after treatment with doxycycline. Arch Dermatol. 1997. 133:49–54.
Article
22. Akpek EK, Merchant A, Pinar V, Foster CS. Ocular rosacea: patient characteristics and follow-up. Ophthalmology. 1997. 104:1863–1867.
23. Michel JL, Cabibel F. Frequency, severity and treatment of ocular rosacea during cutaneous rosacea. Ann Dermatol Venereol. 2003. 130:20–24.
24. Jansen T, Plewig G. Clinical and histological variants of rhinophyma, including nonsurgical treatment modalities. Facial Plast Surg. 1998. 14:241–253.
Article
25. Koo BS, Kwon HJ, Kim BC, Lee KS, Song JY. A clinical study of 133 patients with rosacea. Korean J Dermatol. 1997. 35:405–410.
26. Kim TH, Hwang SM, Lee WS, Ahn SK, Choi EH. A clinical study of rosacea. Korean J Dermatol. 2000. 38:583–588.
27. Lee SY, Choi JH, Sung KJ, Moon KC, Koh JK. A clinical study of 112 patients with rosacea. Korean J Dermatol. 2001. 39:636–642.
28. Shin JB, Kim IH. A clinical study of 90 patients with rosacea. Korean J Dermatol. 2007. 45:1161–1169.